NCT06909409 D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis
| NCT ID | NCT06909409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Idiopathic Pulmonary Fibrosis (IPF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-10-11 |
| Primary Completion | 2026-10-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-10-11 with a primary completion date of 2026-10-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to gain deeper insights into human macrophages and vitamin D, and their interplay, within Idiopathic Pulmonary Fibrosis (IPF). The overall questions, it aims to answer, are the following: Do IPF patients suffer from systemic and local (pulmonary) insufficient levels of vitamin D? Do IPF patients suffer from pro-fibrotic and pro-inflammatory pulmonary macrophages?
Eligibility Criteria
Inclusion Criteria: * A clinical diagnosis of IPF, non-IPF ILD or lung cancer * A signed informed consent Exclusion Criteria: * Do not speak Danish/Do not understand Danish
Frequently Asked Questions
Who can join the NCT06909409 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Idiopathic Pulmonary Fibrosis (IPF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06909409 currently recruiting?
Yes, NCT06909409 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Aarhus to inquire about joining.
Where is the NCT06909409 trial being conducted?
This trial is being conducted at Aarhus N, Denmark.
Who is sponsoring the NCT06909409 clinical trial?
NCT06909409 is sponsored by University of Aarhus. The trial plans to enroll 120 participants.